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In amyotrophic lateral sclerosis (ALS), mitochondrial dysfunction is recognized as one
of the key elements contributing to the pathology. Mitochondria are the major source
of intracellular reactive oxygen species (ROS). Increased production of ROS as well as
oxidative damage of proteins and lipids have been demonstrated in many models of
ALS. Moreover, these changes were also observed in tissues of ALS patients indicative
of important role for oxidative stress in the disease pathology. However, the origin
of oxidative stress in ALS has remained unclear. ALS linked mutant Cu/Zn-superoxide
dismutase 1 (SOD1) has been shown to significantly associate with mitochondria,
especially in the spinal cord. In animal models, increased recruitment of mutant SOD1
(mutSOD1) to mitochondria appears already before the disease onset, suggestive of
causative role for the manifestation of pathology. Recently, substantial in vitro and
in vivo evidence has accumulated demonstrating that localization of mutSOD1 to the
mitochondrial intermembrane space (IMS) inevitably leads to impairment of mitochondrial
functions. However, the exact mechanisms of the selectivity and toxicity have remained
obscure. Here we discuss the current knowledge on the role of mutSOD1 in mitochondrial
dysfunction in ALS from the novel perspective emphasizing the misregulation of dismutase
activity in IMS as a major mechanism for the toxicity.
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INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is a fatal paralyzing disease
characterized by the selective degeneration of motor neurons
in the spinal cord, brain stem and motor cortex. The majority
(∼90%) of ALS cases are sporadic whereas some 10% of patients
have dominantly inherited familial ALS (FALS). However, the
forms share clinical features. The suggested causative factors for
the motor neuron degeneration include oxidative stress, neu-
roimmune reactions, protein aggregation (Boillée et al., 2006)
and mitochondrial abnormalities such as disturbed calcium
homeostasis (Jaiswal and Keller, 2009; De Vos et al., 2012) and
dysfunctional axonal transport (De Vos et al., 2007). Neverthe-
less, the mechanism is yet to be identified. Mutations in sev-
eral genes, including C9orf72, superoxide dismutase 1 (SOD1),
TAR DNA binding protein (TARDBP), Fused in sarcoma (FUS),
angiotensin, alsin, senataxin, and vesicle-associated membrane
protein (VAPB) genes, cause FALS (Finsterer and Burgunder,
2014; Kiernan, 2014). Mutations in the C9orf72 gene are esti-
mated to account for 35% and SOD1 mutations for 20% of
FALS cases. The first gene linked to FALS was SOD1 (Rosen
et al., 1993) and by today more than 150 FALS associated muta-
tions in SOD1 have been identified. There are two types of
mutant SOD1 (mutSOD1) proteins inducing clinically similar
disease: those that show wild type like enzymatic activity and
those with markedly reduced activity (Valentine et al., 2005).
In addition, lack of SOD1 does not lead to development of
ALS in mice (Reaume et al., 1996). Thus, the deleterious
effect of mutSOD1 is thought to involve acquired toxic prop-
erty possibly due to misfolding, aberrant enzymatic activity
(Bruijn et al., 2004) or disturbance of cellular homeostasis by
incorporating into the lipid bilayer membrane (Allen et al.,
2012).
THE ROLE OF SUPEROXIDE DISMUTATION IN
MITOCHONDRIAL HYDROGEN PEROXIDE GENERATION AND
OXIDATIVE STRESS
Reactive oxygen species such (ROS) as superoxide and hydrogen
peroxide (H2O2) are products of normal oxygen metabolism
in cells (Dröge, 2002). They serve as signaling molecules but
when present in excess can harm the structure and functions of
the cell. In the cytoplasm, SOD1 dismutates superoxide anion
radical to H2O2 that is further reduced to H2O by catalase,
glutathione peroxidases or peroxiredoxins (Rhee et al., 2005).
In intermembrane space (IMS), SOD1 has been suggested to
play the similar protective role in handling of superoxide as in
the cytosol (O’Brien et al., 2004; Aquilano et al., 2006; Klöppel
et al., 2010; Fischer et al., 2011; Figure 1, reaction V). How-
ever, in this location, the scavenging systems might not be
efficient enough to eliminate the H2O2 produced by dismuta-
tion. Upon cellular stress and pathological conditions such as
ALS, the elevated H2O2 levels could contribute to mitochondrial
damage.
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FIGURE 1 | Import of SOD1 and CCS into mitochondrial IMS. Unfolded
apoforms of SOD1 and CCS are imported into the IMS of mitochondria
through the translocator of the outer membrane (TOM) (reaction I). In the
IMS, apoCCS interacts with the import receptor, Mia40. Upon this
interaction an intramolecular disulfide bond is formed within CCS trapping
it in IMS (reaction IIa). The translocation of mutant SOD1 (muSOD1) may
take place via alternative mechanism involving the mitochondrial inner
membrane organization system (MINOS) and Mia40 (reaction IIb).
Imported apoSOD1 interacts with mature CCS through a transient
intermolecular disulfide bond (reaction IIIa), which promotes the formation
of the intramolecular disulfide and subsequent trapping of SOD1 in IMS.
Folding of muSOD1 can happen via interaction with CCS or by yet poorly
known mechanisms such as oxidization by H2O2 or protein disulfide
isomerase (PDI)—type of oxidoreductase (IIIb). Alternatively, mutants
unable to fold correctly may form oligomers in IMS (reaction IVb). The
disulfide oxidized mature monomers form the active enzyme by
dimerization (reaction IVa). In ALS, mutant and wt homodimers may
co-exist with heterodimers. Mature dimeric SOD1 dismutates superoxide
(O2−) to O2 and H2O2 (reaction Va). Alternatively, superoxide may react
with CytC3+ which oxidizes it to O2 (Vb). CytC3+ can also catalyze
peroxidation in the presence of H2O2 yielding oxoferryl-cytC (CytCFe4+)
which as a highly reactive oxidant may cause mitochondrial damage
(reaction VI). The critical reactions (Va and VI) leading to mitochondrial
damage are marked with bolded arrows.
Alternatively, superoxide in IMS could be detoxified by
cytochrome C (cytC) which oxidizes it to O2 without pro-
ducing secondary ROS (Figure 1, reaction Vb), thus providing
a safe pathway to eliminate superoxide. However, cytC can
also catalyze peroxidation in the presence of H2O2 yielding
oxoferryl-cytC (CytCFe4+) which is a highly reactive oxidant
(Figure 1, reaction VI). Indeed, we have demonstrated ear-
lier a novel mechanism by which increased dismutase activ-
ity in IMS leads to cytC dependent peroxidation, followed
by mitochondrial dysfunction and apoptosis (Goldsteins et al.,
2008). Cells lacking SOD1 produced less H2O2 and were
less sensitive to apoptosis induced by inhibition of mito-
chondrial respiratory complex III. Moreover, mitochondria
isolated from spinal cords of G93A mice showed increased
dismutase activity and elevated ROS production compared
to wild type (wt) mitochondria. Further in vivo studies
revealed that mutSOD1 in spinal cords of G93A SOD1
rodents is destabilized and bound to the inner mitochon-
drial membrane (Ahtoniemi et al., 2008). These results
raise two essential issues for understanding the mechanisms
of mutSOD1 induced mitochondrial toxicity: translocation
of SOD1 to IMS and activity control of IMS localized
SOD1.
FACTORS REGULATING THE IMPORT OF SOD1 INTO
MITOCHONDRIA
A substantial proportion of SOD1 is found in the mitochondria
(Weisiger and Fridovich, 1973; Jaarsma et al., 2001; Mattiazzi
et al., 2002), concentrated in the IMS (Okado-Matsumoto and
Fridovich, 2001; Sturtz et al., 2001). In mammalian cells, the
mitochondrial localization of SOD1 is regulated by its folding
as it can cross the mitochondrial membrane only in unfolded
disulfide-reduced and non-metallated apo-form (Kawamata and
Manfredi, 2008; Figure 1, reaction I). In addition, it was demon-
strated that the subcellular localization of SOD1 is dictated by
distribution of the copper chaperone for SOD1 (CCS; Kawamata
and Manfredi, 2008). The maturation of SOD1 requires zinc
binding followed by copper insertion and oxygen-dependent
intramolecular disulfide bond formation (Furukawa et al., 2004),
the last two actions being executed by CCS (Culotta et al.,
1997). For proteins such as SOD1 and CCS that lack the mito-
chondrial localization signal, there is a disulfide relay system
in IMS which drives their import (Mesecke et al., 2005). This
Mia40/Erv1 system is involved in the translocation of yeast and
mammalian SOD1 and CCS (Kawamata and Manfredi, 2008;
Reddehase et al., 2009; Groß et al., 2011; Klöppel et al., 2011).
When the reduced apo-proteins enter the IMS, the Mia40/Erv1
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machinery introduces intramolecular disulfide bonds into them
(Herrmann and Riemer, 2010). This folding step traps the
proteins in the IMS as only unfolded precursors can use the
translocator on the mitochondrial outer membrane (TOM) for
exit.
ApoCCS is a direct substrate for Mia40 (Figure 1, reaction
IIa) and the critical cysteines for their interaction in domain I
of CCS were identified by Klöppel et al. (2011). The IMS-located
CCS promotes folding of apoSOD1 and its subsequent trapping
in IMS (Kawamata and Manfredi, 2008; Figure 1, reaction IIIa).
High levels of CCS have been observed in the IMS of yeast and
mammalian cells (Field et al., 2003; Kawamata and Manfredi,
2008) and CCS was found essential for mitochondrial localization
of SOD1 in yeast (Field et al., 2003). Accordingly, the amount
of mitochondrial SOD1 increases upon overexpression of CCS in
mice (Son et al., 2007). In contrast, under the normal cell culture
conditions overexpression of CCS resulted in decreased translo-
cation of both CCS and SOD1 into the mitochondria (Kawamata
and Manfredi, 2008). This appeared to happen because of the
high oxygen concentration which promoted the oxidative folding
of CCS and subsequent maturation of SOD1 in the cytosol.
Lowering the O2 concentration from 20% to 6% that more
resembles the conditions in tissues directed CCS and SOD1
to IMS (Kawamata and Manfredi, 2008). These data indicate
tight O2-dependent physiological regulation of CCS and SOD1
localization.
Redox status of the cysteine residues in human SOD1 is critical
for its retention in mitochondria due to their involvement in
intramolecular disulfide bonds and in the interaction with CCS.
There are four Cys residues in SOD1 (C6, C57, C111 and C146)
which all have a role in mitochondrial import and accumulation
(Kawamata and Manfredi, 2008). An intramolecular disulfide
bridge is formed between C57 and C146 upon maturation (Arne-
sano et al., 2004) thus making these residues essential for the
retention of SOD1 in IMS. C6 and C111 are not involved in
intramolecular bonds but rather in intermolecular interactions
(Niwa et al., 2007; Cozzolino et al., 2008). These interactions
appear to be important as Cys-111 was identified as a key medi-
ator of mitochondrial association in vitro (Ferri et al., 2006) and
mutation in either of the two residues leads to poor accumulation
of SOD1 in IMS (Kawamata and Manfredi, 2008).
A mitochondrial import mechanism for SOD1 independent
of CCS has been described in yeast (Varabyova et al., 2013).
This utilizes the mitochondrial inner membrane organization
system (MINOS) and involves also Mia40. Interestingly, reduced
SOD1 was retained in the mitochondria of CCS null cells in
yeast (Varabyova et al., 2013). In mammalian cells, CCS inde-
pendent mitochondrial import and retention exists for mutSOD1
(Kawamata and Manfredi, 2008).
CONTROL OF SOD1 ACTIVITY BY ITS REDOX STATE, METAL
BINDING AND QUATERNARY STRUCTURE
For maturing into an active enzyme, SOD1 requires three post-
translational modifications: the insertions of zinc and copper,
intramolecular disulfide bond formation, and dimerization. Zinc
is deposited close to the active site stabilizing the structure
(Potter et al., 2007). Copper is required for the enzymatic activity
and is delivered to the catalytic center by assistance of CCS
(Culotta et al., 1997). CCS also participates in the oxidation
of the intramolecular disulfide bond between C57 and C146
in SOD1 (Furukawa et al., 2004) which results from disulfide
transfer involving C244 and C246 in CCS (Banci et al., 2012).
Finally, two metallated and disulfide-oxidized SOD1 monomers
form a dimeric active enzyme via hydrophobic and hydrophilic
interactions. The mature SOD1 is extremely stable due to the
intramolecular disulfide bond which brings stability to the qua-
ternary structure (Arnesano et al., 2004; Hörnberg et al., 2007).
Full activation of human SOD1 requires CCS (Wong et al.,
2000) but an activation pathway independent of CCS also exists
(Carroll et al., 2004). This alternative way of activation requires
reduced glutathione but is independent of oxygen (Carroll et al.,
2004; Leitch et al., 2009). Thus, in contrast to oxygen-dependent
CCS-mediated activation this pathway allows SOD1 activation in
low oxygen conditions. Notably, in tissues of mice null for CCS as
much as 10–20% of SOD1 activity has been observed compared
to wt mice (Wong et al., 2000; Subramaniam et al., 2002).
ABERRANT MITOCHONDRIAL IMPORT AND ACTIVITY
CONTROL OF SOD1 IN ALS
ACCUMULATION OF MUTSOD1 IN MITOCHONDRIA
In ALS, mutSOD1 is recruited to mitochondria especially in the
spinal cord (Higgins et al., 2002; Liu et al., 2004). Oxygen concen-
tration critically influences cellular distribution of CCS and sub-
sequently that of wtSOD1 whereas mutSOD1 appears to be able
to escape this physiological regulation leading to mitochondrial
accumulation of mutants also in the absence of CCS (Kawamata
and Manfredi, 2008). Recently, it was demonstrated that reduced
mutSOD1 enter the mitochondria via CCS-independent route
involving MINOS and Mia40 (Varabyova et al., 2013; Figure 1,
reaction IIIb). In accordance with the implications of the redox
status of Cys residues in human SOD1 for its mitochondrial
association, a variety of SOD1 mutants have been observed to
possess susceptibility to the reduction of disulfide bonds in vitro
(Tiwari and Hayward, 2003). These findings are in agreement
with studies implicating the presence of reduced SOD1 in spinal
cords of ALS mice (Jonsson et al., 2006; Karch et al., 2009;
Zetterström et al., 2013). Even though the in vivo studies did not
assess the localization of reduced mutSOD1, one could expect that
it would be accessible to mitochondria where a part of that pool
could be oxidized. In cell culture, oxidation of Cys111 residues
led to accumulation of several SOD1 mutants in mitochondria
(Ferri et al., 2010). However, another study demonstrated that, in
contrast to wtSOD1, mitochondrial association of mutSOD1 does
not depend on Cys111 (Kawamata and Manfredi, 2008).
Furukawa and O’Halloran (2005) suggested that the reduc-
tion of conserved disulfide bond predisposes SOD1 to incorrect
crosslinking and aggregation (Figure 1, reaction IVb). Certainly,
formation of intracellular aggregates has caught much attention
as it is a hallmark of ALS. Indeed, several mouse models show
correlation between insoluble aggregated forms of mutSOD1
and manifestation of symptoms (Johnston et al., 2000; Wang
et al., 2002, 2003) in concert with findings from human tissues
(Kato, 2008). Moreover, mutants possessing a higher aggregation
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propensity correlated with shorter disease duration in patients
when 33 different SOD1 mutants were studied (Prudencio et al.,
2009). In contrast to that correlation, D101N, I113T and L144F
mutations with low or modest propensity to aggregate pro-
voked rapidly progressing disease (Ayers et al., 2014). Despite
of intensive investigations the mechanism how aggregates would
result in toxicity has remained unclear. It has been suggested
that soluble forms of mutSOD1 initiate the disease (Zetterström
et al., 2007; Karch et al., 2009) and are, in fact, more toxic than
insoluble aggregates (Zetterström et al., 2007; Brotherton et al.,
2012; Weichert et al., 2014). Thus, the key appears to involve
misfolding and the localization in the mitochondria rather than
aggregate formation. Soluble misfolded subfractions of mutSOD1
were found enriched in spinal cords of ALS mice (Zetterström
et al., 2007), and the conformation of such species could facil-
itate mitochondrial translocation. Investigators utilizing anti-
bodies selectively recognizing misfolded/non-native SOD1 have
demonstrated association of misfolded SOD1 with spinal cord
mitochondria in mutSOD1 rodents (Velde et al., 2008; Brotherton
et al., 2012). In cultured motor neuronal cells, obligate expression
of mutSOD1 in IMS leads to mitochondrial toxicity and cell
death (Cozzolino et al., 2009; Magrané et al., 2009). The toxicity
was abolished by overexpression of glutaredoxin 2 possibly via
modulation of disulfide bonds or by affecting mitochondrial
redox environment (Ferri et al., 2010).
Most forms of mutSOD1 show instability in vitro (Rodriguez
et al., 2002, 2005; Lindberg et al., 2005) and mitochondrial mut-
SOD1 has been reported to exist in partially unfolded oligomer-
ized state (Deng et al., 2006; Ferri et al., 2006). Interestingly,
Synofzik et al. (2012) reported on patients carrying a novel SOD1
mutation, L117V, which was indistinguishable from wtSOD1
in terms of stability and dismutase activity resulting in slowly
progressing form of ALS. These findings are consistent with
earlier data demonstrating that even small amounts of misfolded
mutSOD1 are enough to induce ALS (Jonsson et al., 2006). In
addition, overexpressed wtSOD1 is also able to acquire an unsta-
ble, misfolded conformation, leading to motor neuron disease in
mice (Graffmo et al., 2013).
THE ROLE OF DISMUTASE ACTIVITY IN MUTSOD1 INDUCED
MITOCHONDRIAL TOXICITY
The IMS-located SOD1 has been suggested to be inactive in the
intact mitochondria and activated through oxidative modification
of its critical thiol groups by yet poorly known mechanisms
(Iñarrea et al., 2005). Strikingly, overexpression of CCS in G93A-
SOD1 mice results in enhanced mitochondrial recruitment of
SOD1 and drastically accelerates disease progression (Son et al.,
2007). Further, the worsened outcome was independent of pro-
tein aggregation, leaving the possibility of the involvement of
aberrant dismutase activity. Indeed, increased dismutase activity
was found in mitochondria isolated from spinal cords of G93A
mice compared to wt mitochondria and it was accompanied with
elevated ROS production (Goldsteins et al., 2008). Accordingly,
mitochondrial state 4 respiration was increased in spinal cord
and brain mitochondria of presymptomatic G93A rats and it was
coupled with increased production of hydrogen peroxide (Panov
et al., 2011). This is in agreement with observed hypermetabolism
in ALS patients (Bouteloup et al., 2009). In addition, recent data
on pulmonary fibrosis shows that translocation of SOD1 to IMS
leads to increased production of H2O2 (He et al., 2011).
Insertion of copper is required for the activity of SOD1 and
altered copper homeostasis is a common feature in mutSOD1
mice (Tokuda et al., 2013). Cu(atsm) treatment prolongs the
survival of ALS mice (Soon et al., 2011). Importantly, in the
spinal cords of those mice the cytoplasmic dismutase activity
was increased upon copper supplementation. Even though the
mitochondrial activity was not assessed one could hypothesize
that it could be decreased: if more SOD1 is activated in the
cytoplasm then the pool of apo-form capable of entering mito-
chondria should decrease. When mutSOD1 mice were treated
with copper chelator the onset of disease was delayed and the mice
survived longer (Hottinger et al., 1997; Tokuda et al., 2008). This
improvement was accompanied with decreased dismutase activity
in spinal cord homogenates (Tokuda et al., 2008). In cell cul-
ture, copper depletion markedly increased the viability of G93A
motoneurons (Azzouz et al., 2000). In another study, copper
depletion has been shown to increase mitochondrial association
of SOD1 (Arciello et al., 2011). In the latter, the cell viability was
not assessed and the mitochondrial morphology was not altered.
It is possible that in the above mentioned studies on copper
depletion, the mitochondrial import of SOD1 was increased but
due to the lack of copper the enzyme remained inactive and thus
unable to cause mitochondrial damage. However, the lack of CCS,
which provides SOD1 with copper, does not rescue mice from
mutSOD1 induced ALS (Subramaniam et al., 2002). Moreover,
when all four histidine residues that coordinate copper binding
are knocked out from mutSOD1 mice they still develop motor
neuron disease (Wang et al., 2003). These latter two findings
could be explained by alternative ways of SOD1 activation and
by heterodimer formation (Witan et al., 2008, 2009).
In addition to proper folding and metal acquisition, dimeriza-
tion is critical for dismutase activity. Mutant and wtSOD1 are able
to form either homo- or heterodimers both in animal and cell
culture models (Furukawa et al., 2006; Witan et al., 2008; Wang
et al., 2009). Interestingly, wtSOD1 monomer is able to provide
enzymatic activity to the heterodimer where the other monomer
is an inactive mutant (Witan et al., 2008). Furthermore, it was
found that the toxicity of mutSOD1 does not correlate with its
aggregation potential but with the ability to form active dimeric
molecules (Witan et al., 2008). There is some discrepancy in
current data published on the role of wtSOD1 in FALS. However,
most of the rodent models of ALS where wtSOD1 is co-expressed
with mutSOD1 show earlier onset of the disease (Jaarsma et al.,
2000; Fukada et al., 2001; Deng et al., 2006; Wang et al., 2009).
Notably, in the work by Wang et al. (2009) the phenotype was
associated with markedly increased dismutase activity in spinal
cord extracts. Both Furukawa and Wang also confirmed the
existence of heterodimers in vivo, suggesting that formation of
heterodimers may be physiologically relevant in FALS patients as
well. It has been proposed that the heterodimers comprise a pool
of more soluble and more toxic SOD1 whereas homodimers form
less toxic aggregates (Weichert et al., 2014). Furthermore, it was
demonstrated that wtSOD1 actually reduces aggregate formation
of mutSOD1 in cell culture (Witan et al., 2009). How different
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dimers affect mitochondrial dismutase activity and H2O2 produc-
tion is not known and warrants further elucidation. In the model
proposed (Figure 1, reaction IV) enzymatically active homo-
and heterodimers all contribute to dismutation of superoxide.
Accumulation of these dimers leads to increased activity which is
likely augmented by loss of physiological controlling mechanism.
Subsequent increase in H2O2 leads to cytC catalyzed peroxidation
and mitochondrial damage.
CONCLUSIONS
Under physiological conditions SOD activity in IMS is suppressed
by redox state control. However, upon mitochondrial stress SOD1
may undergo oxidative activation and compete with cytochrome
C for superoxide released in the IMS, leading to increased ROS
production. In ALS, mutSOD1 accumulates in IMS, thus con-
tributing to the misregulation of dismutase activity. The presence
of endogenous wt enzyme may provide dismutase activity to
inactive mutant by heterodimerization. Here we propose that
aberrant regulation of dismutase activity in IMS as a major
mechanism for the toxicity should be further evaluated in future
studies. Furthermore, the possible involvement of mitochondrial
IMS dismutase activity misregulation in sporadic ALS warrants
careful assessment.
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